Canna~Fangled Abstracts

A survey of cost, access and outcomes for cannabinoid-based medicinal product use by Australians with endometriosis

By February 28, 2024March 5th, 2024No Comments

. 2024 Feb 28.

doi: 10.1111/ajo.13804.

Online ahead of print.
Andrew Proudfoot 1, Sarah Duffy 2, Justin Sinclair 1, Jason Abbott 3 4 5, Mike Armour 1 6 7
Affiliations 

Abstract

People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a ‘cannabis clinic’ doctor, incurring an initial consultation cost of $100-$200+ (10.2% Medicare bulk-billed) and median cannabinoid medicine costs of $300AUD per month. Cost was a major barrier to access, necessitating reducing dosage (76.1%) and/or consuming illicit cannabis (42.9%), despite a prescription. Most (77%) medical consumers used two or more cannabis products, with delta-9-tetrahydrocannabinol predominant oil and flower products most frequently prescribed.

Keywords: CBMP, administration method, cannabis, chronic pain, dose, endometriosis, insurance

PubMed Disclaimer

References

REFERENCES

    1. Rowlands IJ, Abbott JA, Montgomery GW et al. Prevalence and incidence of endometriosis in Australian women: A data linkage cohort study. BJOG 2021; 128(4): 657-665.
    1. Armour M, Lawson K, Wood A et al. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey. PLoS One 2019; 14(10): e0223316.
    1. Evans S, Villegas V, Dowding C et al. Treatment use and satisfaction in Australian women with endometriosis: A mixed-methods study. Intern Med J 2021; 52: 2096-2106.
    1. Sinclair J, Toufaili Y, Gock S et al. Cannabis use for endometriosis: Clinical and legal challenges in Australia and New Zealand. Cannabis Cannabinoid Res 2021; 7: 464-472.
    1. Armour M, Sinclair J, Cheng J et al. Endometriosis and cannabis consumption during the COVID-19 pandemic: An international cross-sectional survey. Cannabis Cannabinoid Res 2022; 7(4): 473-481.

LinkOut – more resources

  • Full Text Sources

Leave a Reply